Pfizer has said its drug to treat Covid-19 reduced the risk of hospitalization or death due to the disease by 89% compared to a placebo.
Pfizer has said its drug to treat Covid-19 reduced the risk of hospitalization or death due to the disease by 89% compared to a placebo.